Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Details within the Details.
Don’t matter, 2022 is our year!
https://stocktwits.com/Austero/message/378934828
Next 60 days will be interesting. Couple things to track:
- 10Q filing on or near Aug. 13th
- 2nd Clinic open end of Aug. or first of Sept.
I’d like to see an update on Denver. Simply that hiring a NP has taken place.
The waiting is the hardest but we did the same last year. July 2020 it ran to 0.08 then fell back to 0.02… waited for 6 month and watched it run > 2,000%
My primary reason to go long term is the all star executive here.
It’s called a “deal” iRobber
Not all deals and partnerships are created equal.
Look at it this way… CUBT could either not have a deal and have zero or be part of the play and get their cut.
Animal models at any locations is allowed as they can be submitted to be published for peer review and propose hypothesis of drug mechanisms of actions.
With that being said… CUBT .. imo… may attempt 2 parts to the study… I think it would be cool to see metformin eye drops (various strengths) be given independently and also metformin eye drops given PLUS Dr Bharti stem cells …. I think this coupled technology may provide an interesting trial
Dr Bharti says in his bio… interest in stem cells and drug-based therapies
OceanDrive you are telling DarkLady you have way too much in this. You must not know her credentials
She sits here as a General holding the SP in her hands as we are all soldiers!
She has the best advice for everyone! Hold and be rewarded.
OceanD the time waiting on this one will prove valuable.
Sounds like all on ST and ihub are longterm investors and you are unrealistic in wanting overnight success. This takes time to develop. Whether is 4 clinics, 8 clinics, or 16 clinics end of year they all equal GROWTH!
Main thing here to watch for is that the company continues its progress with bringing on exec and medical talent, getting the word out like interviews, and completing real estate and legal requirements to secure spaces.
SP will never do what you want when you want it to. Think 2023.
Metformin is a familiar world wide drug. Eye drop formulation and clinical trail will cause excitement! In share price too.
Nothing related but I recall Joe Rogan himself having a podcast devoted to the potential use of metformin as anti aging drug with a geneticist.
Ox, thanks! You have clearly explained to all this point. Anyone continuing to post on the topic either doesn’t understand it or is just being a distraction.
3 items I’m tracking: Form 10, NDA for Metformin within 6 months, and Clinical Trails by Q3 2022.
Keep adding before it runs!
I imagine this your last post since you’re ready to leave MEDH. Cause I can’t understand why you are still here Lol.
You’re like a fan who is a critic but continues to wear their team jersey and show up to the house parties just to eat.
The only plan.
Whether old or new. Merger into DAZE is the only plan.
Hans will continue to receive an ass chewing until that plan solidifies lol
Better plan is the only plan….. Merge private companies into MEDH and rename it DAZE.
Active situation going down on Twitter right now.
Hans is having a wild good time. Possibly a meeting and immediate action or destruction lol
https://mobile.twitter.com/The1OnlyHans?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Lol. Point made.
CurbOnTheGo sipping on MaiTai’s down in Boca Raton?
https://www.govinfo.gov/content/pkg/FR-2020-08-28/html/2020-18988.htm
Hard to believe they scammed The National Cancer Institute, an institute of the National
Institutes of Health, Department of Health and Human Services.
Development plan for Glioblastoma drug anticipates being prepared for First-in-Human clinical trial within 18 months. 18 months is around March 2022.
Still a window to develop.
We should direct questions to Michael K. Fish - Independent Director and Chairman of the Audit Committee. Would hope the licensed CPA has some integrity.
Agreed. Longterm $3/share…
Longterm meaning not shorter then swing traders patience.
This will be a success story but it won’t happen overnight. If your adding you are in a wonderful position. If your trying to sell just wait and you will always get your chance at 0.20 towards dollars
I agree. Would remove the linear thought process on clinics and look enticing to institutional investors.
I believe Sheila will be leverage in a M&A in the future on the tech/tele side. Their referenced Telehealth competitor AM*WL is strictly Telehealth with market cap of 3 billion (that’s $15 in miti speak).
Two outcomes for the highly promoted Quarter 2 by Hans.
1. Material event
2. Statement of delay on material event
At least hoping to hear from MEDH through official PR and not Twitter showing wings and beer along with a so called irrigation system. My concern is I’ve seen real irrigation systems both above ground and drip and that ain’t it. Hans posted a garden system.
Staying hopeful. Will add at these prices for sure
The FBI & SEC needs to hire you to investigate the hedge funds. You are no dummy for sure.
Impressive. Sincerely use these post as your resume and contract out to the Feds.
Love the message but not to sure about the cited article from Feb 2020 unless you are saying that’s the initial research that caught Paul’s interest. I do think once trials or intent filing of IND happens it will for sure bring on money!
Adding/Holding
0.10 would be awesome
https://www.google.com/amp/s/www.investorsobserver.com/news/stock-update/amp/mitesco-inc-miti-stock-is-lower-after-announcing-expansion-of-the-good-clinic
Can’t wait til “Shares of MITI declined 3.32% to $2.7”
Love $2.70
iRobot I’m seriously trying to help you understand this. Just load and hang in there.
I’m saying we may not get to clinical trials until 2022. To do this right company must execute each step perfectly like GMP and writing of Protocols.
I don’t know when we can reach pps >$3. I’m saying if we take all 3 drugs and reach at least phase 3 then yes >$3 pps.
But we may not even make it that far... Five Prime had only completed Phase 2 before acquisition.
Load and hold for a great opportunity
$CUBT Market Cap - $38M. (Value of our licenses without any clinical phase trials initiated). Appropriate.
Cost is independent to each developer however we can estimate valuation. Sources available online. I believe our target for trials is 2022.
https://curativebiotech.com/pipeline
Value at start of program
$0M
Probability of FDA approval: 4%
Investment required for approval: $559M
Value at start of Phase 1
$88M
Probability of FDA approval: 12%
Investment required for approval: $520M
Value at start of Phase 2
$248M
Probability of FDA approval: 20%
Investment required for approval: $486M
Value at start of Phase 3
$1,119M
Probability of FDA approval: 56%
Investment required for approval: $405M
Reference: baybridgebio
As for Probability our share price will increase regardless due valuation based on potential. Plus we are phase 3 eligible due to orphan drug status.
Finally a COMPARISON EXAMPLE:
A Phase 3 Ready Monoclonal Antibody like CUBT’s acquired for $1,900M ($1.9 billion)!!!
https://www.amgen.com/newsroom/press-releases/2021/03/amgen-to-acquire-five-prime-therapeutics-for-$1-9-billion-in-cash
Estimate >$3 pps for CUBT
I know Generals who command soldiers from a remote/virtual office and are just as lethal and decisive from that seat.
Brick & Mortar doesn’t make the man, vision does.
Im not investing in real estate here. If you want commercial property investment go check out a REIT
iRobot let me help you with Biotech/Pharma developments.
The have received licenses from NIH (repository for all US drugs) to proceed to clinical trials with global rights to markets. If a drug for rare (pediatric eye or brain cancer) or tropical disease (rabies) is brought to market then the FDA will award the company a Voucher (kinda like a golden ticket) that can be used to fast track a future drug or sell to another company at a value at about $125- $200 million each. We are set to possibly achieve 3 vouchers in the future.
A Patent is assigned to the inventor, such is the case of Dr Dimitrov and his/our monoclonal antibody targeting CD56. Dr Dimitrov is our clinical advisor and Dr Boulis is our neurosurgeon who will develop technique for drug administration.
Bro, just load and hold. This will happen eventually
Technicals are setting up. Going to be a great year.
Gotta ask.
Do you know of any relationship with Takeda Pharmaceuticals and Paul?
DarkLady would tell Larry his share count is cute!
Mitesco Bull!!! Been a year, no?
Give us the goods! Let’s hear here it
You have an eye for spotting concerns most of us would overlook. I guess we will see in a quarter how accounting unfolds.
We should be able to email through IR a specific question to our CFO and ask for clarification on accounting principles MITI will adopt.
Appreciate your posts as always!
I do recall your home health pitch last summer. Would have been nice. Wonder what the next area in healthcare they will acquire next.
Have not read 10Q and am not a medical biller.
But, keep in mind healthcare insurance reimbursement is not in real time. Can take up to days, weeks, to couple months to receive payment.
Typically I would assume their is a standard reimbursement turn around time. If anyone knows a Medical Office biller it’s worth asking.
Love the weak and fearful sentiments... love to see them paper hands second guess themselves
CUBT long! Great fortunes await!
$2 to uplist to NYSE/American.
The Good Clinic will take MITI multi-dollars
But wait until the next company in a complimentary or different healthcare space is acquired.
MITI is a holding company (Incubator/Accelerator model)
Life changing opportunity for all.... IMO
Float 218 mil as of 3/31
Add!
They getting the collaboration agreement with the manufacturing facility IMO.
I’ll continue to add as long as it takes. Love the OTC thrill!
All gas, no brakes! Even down hill, Lol
As long as delay for N&S I would assume PR’s were stacked and ready to unfold.
Need to get some encouragement to engage the base.
we sound like hungry lions moaning and roaring for a bone or scrap!
Love the OTC !!! Full of excitement, thrill, and gut wrenching suffering!
Agree... keep adding. For those late .10 to .19 is a great position to build
.20’s soon
Appreciate that perspective.